Form 4: LifeStance Health Group Officer Reports Stock Transactions

Paula Cipollone, a Business Transformation Officer at LifeStance Health Group, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Summary

• Paula Cipollone, a Business Transformation Officer at LifeStance Health Group, filed a Form 4 detailing changes in beneficial ownership.
• On March 8, 2024, Cipollone acquired 62,413 restricted stock units (RSUs), each representing a contingent right to receive one share of LifeStance Health Group's common stock.
• Additionally, 32,052 performance-based restricted stock units vested on March 8, 2024.
• On March 11, 2024, Cipollone sold 13,996 shares of common stock at a price of $6.93 per share.
• This sale was to cover tax withholding obligations related to the vesting of the RSUs and was not a discretionary trade.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is primarily driven by tax obligations.

Key Dates